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Plasma Ang2 and ADAM17 levels 
are elevated during clinical malaria; 
Ang2 level correlates with severity 
and expression of EPCR-binding 
PfEMP1
Jens E. V. Petersen1,*, Sixbert I. Mkumbaye2,*, Anna V. Vaaben1, Alphaxard Manjurano3, 
Eric Lyimo3, Reginald A. Kavishe2, Steven B. Mwakalinga2, Jacklin Mosha3, Daniel T. R. Minja4, 
John P. A. Lusingu4, Thor G. Theander1, Thomas Lavstsen1 & Christian W. Wang1
The pathogenesis of Plasmodium falciparum malaria involves a complex interplay between parasite 
adhesion and inflammatory response that includes release of cytokines and activation of the 
endothelium with accompanying release of Angiopoitin 2 (Ang2) to the plasma. A-disintegrin and 
metalloproteinase 17 (ADAM17) is a protein responsible for releasing cytokines, including Tumor 
Necrosis Factor α (TNFα), and shedding of adhesion proteins. In this study, we show that plasma levels 
of ADAM17 are increased in Tanzanian children hospitalized with a malaria infection compared with 
asymptomatic children but similar to children hospitalized with other infectious diseases. The plasma 
levels of ADAM17 decreased during recovery after an acute malaria episode. Plasma levels of Ang2 
were associated with markers of malaria severity and levels of var transcripts encoding P. falciparum 
Erythrocyte Membrane Protein 1 (PfEMP1) containing Cysteine Rich Inter Domain Region α1 (CIDRα1) 
domains predicted to bind Endothelial Protein C receptor (EPCR). ADAM17 levels were not associated 
with expression of var genes encoding different PfEMP1 types when controlling for age. These data are 
the first to report ADAM17 plasma levels in malaria-exposed individuals, and support the notion that 
parasite sequestration mediated by EPCR-binding PfEMP1 is associated with endothelial activation and 
pathology in severe paediatric malaria.
In 2015, there were between 150 and 300 million malaria cases worldwide, causing an estimated 438,000 deaths of 
which 90% occurred in Sub-Saharan Africa1. The most vulnerable group is children under the age of five infected 
with Plasmodium falciparum. Even with the current artemisinin combination treatments, infected individuals are 
at a high risk of dying if they develop symptoms or signs of severe malaria (SM). Clinical manifestations of SM 
are typically cerebral malaria (CM), respiratory distress (RD), severe malarial anaemia (SMA), and hyperparasi-
taemia and they often overlap in individual patients. A hallmark of a P. falciparum infection is the sequestration 
of infected erythrocytes (IEs) to the host microvasculature2. To avoid splenic clearance, the parasite adheres to 
the vasculature by expressing P. falciparum Erythrocyte Membrane Protein 1 (PfEMP1) binding infected erthro-
cytes to endothelial host receptors such as cluster of differentiation 36 (CD36) and endothelial protein C receptor 
(EPCR)3.
PfEMP1s are encoded by var genes, and each P. falciparum genome contains about 60 different var genes that 
are divided into four main groups: A, B, C, and var2csa, correlating both with genomic location and direction 
of transcription, sequence similarity and receptor binding phenotype3–6. Thus, group A PfEMP1s, characterized 
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by having an N-terminal Duffy-binding like α 1 (DBLα 1) domains followed by either a CIDRα 1 domain, which 
is predicted to bind EPCR or a CIDRβ , γ , or δ domain, which are potentially linked to rosetting (IE binding 
of uninfected erythrocytes). Group B and C PfEMP1s have N-terminal DBLα 0-CIDRα 2-6 domain cassettes 
(co-occurring domain subtypes) predicted to bind CD36. A special set of PfEMP1s, the domain cassette 8 (DC8) 
PfEMP1, have evolved as an intermediate of group B and A PfEMP1. The DC8 PfEMP1 also bind EPCR via the 
CIDRα 1.1 or 1.8 domain subtypes. Parasite sequestration is a major driver of the pathogenesis of an P. falciparum 
infection2, and sequestration via EPCR-binding PfEMP1s has been strongly associated with the development of 
SM3,7–9.
P. falciparum infections activate the innate immune system causing release of inflammatory cytokines. Of par-
ticular importance is Tumor Necrosis Factor α (TNFα ), a proinflammatory cytokine that induces fever, cachexia, 
and apoptosis of endothelial cells10,11. TNFα is increased in malaria patients and has been associated with the 
severity of infection12. TNFα is released by A-disintegrin and metalloproteinase 17 (ADAM17), primarily from 
macrophages where it is expressed on the surface and subsequently cleaved off13. ADAM17 was initially discov-
ered as the metalloproteinase responsible for cleaving and releasing TNFα and is therefore also known as TNFα 
converting enzyme (TACE)13.
ADAM17 mediates shedding of multiple other cytokines and cytokine receptors, including colony stimulating 
factor 1 (CSF1), TNFα receptor (TNFα R) and interleukin 6 receptor (IL6R)14. ADAM17 also mediates shed-
ding of proteins involved in leukocyte-endothelial cell interactions, such as L-selectin and intercellular adhesion 
molecule-1 (ICAM-1)14,15, as well as a range of other surface receptors including EPCR14,16. Thus, ADAM17 may 
influence availability of host receptors utilized by IE in malaria. Absence of EPCR-staining at sites of the brain 
with sequestering IEs suggests that EPCR is cleaved off the endothelium or internalized as a consequence of 
sequestration, potentially exacerbating the vascular pathology by impairing the functions of activated Protein C 
(APC)17.
The interaction between EPCR and PfEMP1 is also thought to enhance the vascular pathology, as PfEMP1 
binding to EPCR blocks the binding of the natural EPCR ligand, Protein C (PC), in vitro6,18. In vitro, PfEMP1 
binding to EPCR reduces PC activation and dampens APC’s anti-inflammatory effects, including the ability to 
protect against thrombin-induced barrier disruption19,20. In the absence of APC-EPCR engagement, thrombin 
cleaving of protease-activated receptor 1 (PAR1) results in enhanced signaling for release of Weibel-Palade Bodies 
(WPBs).
Angiopoietin 2 (Ang2) is a growth factor molecule released from WPBs21. Elevated plasma concentrations of 
Ang2 reflect endothelial activation and are correlated with SM and risk of death22,23. Ang2 competes with Ang1 
for binding to the receptor tyrosine kinase Tie2, which upon Ang2 binding decreases endothelial barrier integrity. 
The auto-/paracrine signaling initiated by Ang2 is involved in the transmigration of leukocytes by destabilizing 
the endothelium24,25.
In addition to the presence on leukocytes, ADAM17 is also found along with Ang2 in the WPBs of endothelial 
cells26. Little is known about ADAM17 in malaria, but the cleavage of host receptors specifically utilized by IEs in 
severe malaria patients and cytokines, such as TNFα , which are increased in SM, suggests ADAM17 plays a role 
in malaria pathogenesis. This study investigated the plasma levels of ADAM17 and Ang2 in Tanzanian children 
admitted to the hospital with UM, SM, or with other infections, and the potential correlations between ADAM17 
or Ang2 and PfEMP1 subtype expression.
Results
Study population. Characteristics of the study population are presented in Table 1. Children with CM, 
SMA, RD, hyperparasitaemia were diagnosed as severe malaria (SM). The patients in UM and SM groups were 
of equal age distributions, the children hospitalized with infections other than malaria were of younger age 
(P < 0.0001, Table 1), while the children with asymptomatic malaria infections were older (P = 0.02, Table 1).
Plasma ADAM17 is elevated in hospitalized children. To determine whether ADAM17 plasma levels 
were associated with clinical malaria, we measured ADAM17 plasma levels by ELISA. Children with UM had 
a median ADAM17 plasma level of 2,329 pg/mL, and children with SM had a similar median of 2,423 pg/mL 
(Fig. 1a). Asymptomatic children had lower levels of ADAM17 than children with UM or SM with a median of 
490 pg/ml (P = 0.04 and P = 0.01, respectively). The median ADAM17 level for the non-malaria patient group 
was 2,418 pg/ml, similar to UM and SM patients. We observed no difference in the ADAM17 levels between 
UM and SM patients of Korogwe and Magu. The non-malaria patient group had a higher median level than the 
asymptomatic children (P = 0.03). Plasma levels of ADAM17 during acute malaria were compared to plasma 
levels during recovery in samples collected at admission from hospitalized children (Table 1) and from the same 
children between 2 to 12 weeks after admission (Fig. 1b). In the plasma from convalescent patients, the ADAM17 
levels were significantly decreased to a median of 1,180 pg/ml (P < 0.0001). There was no statistically significant 
difference between ADAM17 levels in convalescent patients and the asymptomatic malaria children (P = 0.2), 
and ADAM17 plasma levels samples were negatively correlated with the time progressed since diagnosis (Fig. 1b, 
P = 0.0001). Among non-malaria patients, the ADAM17 levels did not differ significantly between the following 
three groups; septicemia and/or meningitis, pneumonia or submandibular swelling, and those with gastroen-
teritis or urinary tract infections (P = 0.3, Fig. S1a). ADAM17 levels were also measured in the plasma from 33 
healthy Danish adults (median of 377 pg/ml) and were similar to the levels found in the asymptomatic children 
(Supplementary Fig. S2a).
Ang2 plasma levels are elevated in children with severe malaria. Ang2 plasma levels have previ-
ously been shown to correlate with the severity of a malaria infection23. We found that Ang2 levels were signifi-
cantly higher in SM patients compared with UM patients (SM median 2,195 pg/ml vs. UM median 1,461 pg/ml, 
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P < 0.0001, Fig. 2). The median Ang2 plasma levels in individuals with asymptomatic malaria (median 926 pg/ml) 
or hospitalized with non-malaria infections (median 884 pg/ml) were both significantly lower than in the SM 
group (P < 0.0001). There was no statistically significant difference between the Ang2 levels of those with UM and 
asymptomatic malaria. Within the non-malaria groups, the Ang2 levels did not differ significantly between the 
different non-malaria cases (P = 0.4, Supplementary Fig. S1b). In plasma from healthy Danish adults we found 
a median Ang2 level of 576 pg/ml (Supplementary Fig. S2b). When looking at Magu and Korogwe individually, 
both had an increased Ang2 in SM compared to UM (P = 0.0002 and P = 0.0004, respectively). The levels of 
Ang2 in SM patients were higher in Magu compared with Korogwe (P < 0.0001), while the levels of Ang2 in UM 
patients did not differ significantly (P = 0.1).
Ang2 but not ADAM17 plasma levels are associated with malaria severity in hospitalized 
children. As we found no difference in ADAM17 levels between the UM and SM groups, these were grouped 
for the further analysis of factors or variables correlated with the ADAM17 levels in patients hospitalized with 
malaria. We found no correlation with any of the symptoms or signs previously associated with increased risk of 
fatal outcome of a malaria infection and plasma ADAM17 levels, such as low Hb, high lactate, or Blantyre coma 
score < 3. ADAM17 levels were correlated with Ang2 (P = 0.002, Table 2), weakly correlated with the marker for 
parasite biomass HRP2 (although not statistically significant when correcting for multiple testing, Rho = 0.17, 
P = 0.03), and ADAM17 levels were inversely correlated with age (P = 0.001). By contrast, Ang2 plasma levels 
were inversely correlated with Blantyre coma score (P = 0.0002) and Hb-levels (P < 0.0001) and positively corre-
lated with lactate (P < 0.0001), but had no significant correlation with age or parasitaemia (both when measured 
as circulating erythrocytes or by analyzing plasma levels of HRP2) (Table 2).
Ang2 but not ADAM17 plasma levels are associated with PfEMP1 type expression. IE seques-
tration via the PfEMP1-EPCR interaction is thought to affect pathology through occlusion of blood flow and 
promotion of coagulation and inflammation27.
We utilized var transcript profiles of the UM and SM individuals (Mkumbaye et al., submitted), to explore 
Ang2 and ADAM17 plasma level correlations with expression of specific var subsets, encoding PfEMP1 predicted 
to bind or not to bind EPCR. Group A PfEMP1 expression levels were estimated by the “DBLa1all” primer set. 
The DBLa1all reported expression levels that correlated with Ang2 plasma levels but not with ADAM17 plasma 
levels (Table 2). Group A transcripts targeted by the DBLa2/1.1/2/4/7 primers typically encode EPCR-binding 
CIDRα 1 domains7. Abundance of such transcripts also weakly correlated with Ang2 (Rho = 0.25, P = 0.002), 
whereas group A transcripts encoding PfEMP1 not binding EPCR (reported by the DBLa1.5/6/8 primers) were 
not correlated with Ang2 plasma levels (P = 0.27) (Table 2). When investigating transcript levels reported by 
primers specific for genes encoding different EPCR-binding CIDRα 1 subtypes, we found a weak correlation 
between plasma levels of Ang2 and the abundance of transcripts encoding CIDRα 1.1 (DC8) (Rho = 0.25, 
P = 0.001, Table 2) and CIDRα 1.4 (DC13) domains, although CIDRα 1.4 was not statistically significant when 
using Bonferroni’s correction for multiple testing (Rho = 0.18, P = 0.02; Table 2). ADAM17 plasma levels were 
weakly correlated with the abundance of CIDRα 1.1 encoding transcripts, however, this correlation was not sta-
tistically significant with Bonferroni’s correction (Rho = 0.18, P = 0.02; Table 2). We observed no statistically 
significant correlation between expression of PfEMP1 containing CIDRα 3.1 and CIDRα 3.2 predicted to bind 
CD36 (primer CIDRa3.1/2) and Ang2 plasma levels or ADAM17 plasma levels (Table 2).
Next, we evaluated the Ang2 plasma level in relation to the correlated components. As the Bonferroni’s cor-
rection applied in the univariate analysis is quite conservative, we chose to include all variables correlated with a 
P value below 0.05 to include testing of possible false negatives, Hb, lactate, parasitaemia, Blantyre coma score, 
CIDRα 1.4, CIDRα 1.1, and ADAM17 in a general multiple linear regression analysis with backwards elimina-
tion of covariates (controlled for age and location). We found that Hb, lactate, CIDRα 1.4, and ADAM17 were 
Patient characteristics
Village infections 
(VI) (n = 6)
Uncomplicated 
malaria (UM) (n = 39)
Severe malaria (SM) 
(n = 123)
Non-malaria 
hospitalized (n = 32)
*Acute SM/
Convalescent (n = 19)
Age (years), mean [IQR] Min-max 9.4 [5.8–11.5] 5.2–16.9 3.0 [2.0–4.0] 0.2–7.0 2.8 [1.6–4.0] 0.1–9.2 1.5 [0.6–2.2] 0.2–4.9 2.5 [1.3–3.5] 0.3–4.2
Sex, n (M/F) 3/3 16/23 60/63 21/11 10/9
Location, n (Korogwe/Magu) NA 32/7 75/48 32/0 19/0
Parasitaemia, median (p/μL) [IQR] 989 [363–1,650] 12,500  [5,080–45,000]
272,000  
[35,000–512,200] NA
17,000  
[9,900–427,000]
HRP2, median (μg/mL) [IQR] 435 [158–3371] 1662 [92–3215] 3989 [868–8013] 0 [0–0] 1715 [1020–2380]
Temperature, median (°C) [IQR] 37.1 [36.8–38.2] 38.0 [37.6–39.7] 38.4 [37.7–39.4] 39.3 [38.9–39.8] 38.8 [38.1–39.1]
Haemoglobin, mean ± sd (g/dL) Min-max 11.3 ± 2.6 6.7–14.7 9.9 ± 2.0 8.1–20.2 6.16 ± 2.3 2.4–11.3 9.1 ± 1.6 5.6–12.2 5.9 ± 2.9 6.7–14.7
Blantyre coma score, mean [IQR]Min-max NA 5 [5–5] 5–5 3.6 [2–5] 0–5 4.8 [5–5] 1–5 4.5 [5–5] 2–5
Lactate, mean ± sd (mM) Min-max NA 3.4 ± 1.8 1.4–9.0 5 ± 3.4 0.9–17.2 3.1 ± 1.2 1.5–6.1 5.5 ± 3.1 1.1–13.1
Mortality, n (%) 0 0 9 (7) 1 (3) 0
Convalescent sample, mean (weeks) Min-max NA NA NA NA 6.3 2.4–10.7
Table 1.  Clinical characteristics of patients. *For 19 SM cases a convalescent plasma sample was taken. 
IQR = Inter Quartile Range, sd = Standard deviation.
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statistically significant explanatory variables for Ang2 plasma levels (Table 3). We evaluated the correlations 
found between ADAM17 plasma levels and age, HRP2, Ang2 plasma levels, CIDRα 3.1/2 expression, and expres-
sion of CIDRα 1.1 in a general multiple linear regression analysis with backwards elimination of covariates. We 
found that CIDRα 1.1 expression was not a statistically significant explanatory variable for ADAM17 levels, while 
age and Ang2 levels were statistically significant explanatory variables (Table 4).
Discussion
The pathology of malaria is the result of a complex interplay between inflammatory response, endothelial activa-
tion, parasite sequestration, and loss of erythrocytes. An increased amount of cytokines released by ADAM17 and 
endothelial activation with associated increase in plasma levels of Ang2 have been reported in malaria patients23. 
Parasites expressing EPCR-binding PfEMP1 are associated with SM6,7,28, and expression of group A PfEMP1s 
(EPCR and non-EPCR-binding PfEMP1) has been correlated with increased Ang2 plasma levels29.
In this study, we investigated the plasma levels of ADAM17 and Ang2 in children in north-eastern and 
north-western Tanzania hospitalized with malaria infections in relation to PfEMP1 expression, and the clini-
cal parameters; Hb, lactate, Blantyre coma score, and parasitaemia. We found ADAM17 plasma levels elevated 
in hospitalized children with malaria compared with children with asymptomatic malaria infections. However, 
the ADAM17 plasma levels were similar between children with UM, SM, and other infectious diseases. During 
malaria convalescence, ADAM17 plasma levels markedly declined to levels similar to those of asymptomatic 
malaria-infected children. The increased ADAM17 concentrations in the plasma may be part of a general inflam-
matory response to infection and seemed to be unspecific.
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Figure 1. ADAM17 plasma levels. (a) Boxplot of ADAM17 plasma levels for children with either 
asymptomatic malaria (AS, n = 6), uncomplicated malaria (UM, n = 39), severe malaria (SM, n = 123), or 
children admitted to the hospital without malaria (Non-mal, n = 32). The boxplots display median, 1st quartile 
(Q1), and 3rd quartile (Q3). The lower whisker indicates the lowest data point above Q1 minus 1.5 times IQR, 
the upper whisker indicates the highest data point below 1.5 IQR plus Q3. Values below Q1 minus 1.5 IQR and 
above Q3 plus 1.5 IQR are indicated as points. Statistical significance was calculated using Kruskal-Wallis test 
and pairwise comparisons using Dunn’s Test with Bonferroni correction. *P < 0.05. (b) Acute/convalescent 
plasma levels of ADAM17 samples from 19 children hospitalized with malaria. Acute samples taken at t = 0, 
convalescent follow-up samples were taken between 2 and 12 weeks after the hospitalization. ADAM17 data is 
log-transformed. Linear model in blue with 95% confidence interval in grey (P-value = 0.0001).
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In line with previous studies, Ang2 plasma levels were increased in SM patients compared with UM patients 
and non-malarial patients23,29. Ang2 levels in SM cases appeared higher in Magu than in Korogwe, while the UM 
cases had similar Ang2 levels. Ang2 levels, unlike ADAM17, correlated with markers of disease severity, such 
as Blantyre coma score, Hb- and lactate levels in children hospitalized with malaria. We also observed a weak 
correlation between Ang2 and ADAM17. Ang2 is released to the plasma from WPBs of activated endothelial 
cells21, and ADAM17 is co-localized with Ang2 in the WBPs26, which could explain this correlation. However, as 
ADAM17 plasma levels seem to be elevated as a response to disease in general, whereas Ang2 plasma levels are 
particularly increased in SM, it seems unlikely that the increase of ADAM17 plasma levels was primarily due to 
activation of endothelial cells and subsequent release of WPB. ADAM17 sheds EPCR, and loss of EPCR from the 
endothelial cell surface or of EPCR function may lead to a rise of plasma Ang230. However, the origin of ADAM17 
in plasma is unknown. Secretion of enzymatically active ADAM17 on extracellular microparticles has been found 
in the plasma and associated with disease activity of anti-neutrophil cytoplasmic antibody (ANCA)-associated 
vasculitis26. ANCA-associated vasculitis, as malaria, features an excessive inflammatory response, which leads to 
the shedding of adhesion molecules and cytokines, such as TNFα 31,32.
ADAM17 sheds EPCR, and thus the increased plasma ADAM17 during acute malaria infections may 
have consequences for the survival of EPCR-binding parasites and for regulation of inflammation, including 
increased levels of plasma Ang2. However, ADAM17 plasma levels were not associated with reduced expression 
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Figure 2. Angiopoietin 2 (Ang2) plasma levels. Boxplot of Ang2 plasma levels for children with either 
asymptomatic malaria (AS, n = 6), uncomplicated malaria (UM, n = 39), severe malaria (SM, n = 123), or 
children admitted to the hospital without malaria (Non-mal, n = 32 The boxplots display median, 1st quartile 
(Q1), and 3rd quartile (Q3). The lower whisker indicates the lowest data point above Q1 minus 1.5 times IQR, 
the upper whisker indicates the highest datapoint below 1.5 IQR plus Q3. Values below Q1 minus 1.5 IQR and 
above Q3 plus 1.5 IQR are indicated as points. Statistical significance was calculated using Kruskal-Wallis test 
and pairwise comparisons using Dunn’s Test with Bonferroni correction. ***P < 0.0001.
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ADAM17 Ang2
Rho P value Rho P value
Age − 0.24 0.0013* − 0.014 0.86
Hb − 0.10 0.15 − 0.39 0.0000006*
Lactate 0.08 0.34 0.35 0.0001*
Parasitaemia − 0.05 0.50 0.15 0.06
HRP2 0.17 0.03 0.07 0.42
Blantyre score − 0.02 0.84 − 0.29 0.0002*
Ang2 0.18 0.02
DBLa1all 0.1 0.21 0.24 0.002*
 DBLa2/1.1/2/4/7 0.10 0.19 0.25 0.002*
 DBLa1.5/6/8 0.09 0.23 0.09 0.27
CIDRa1.all 0.08 0.34 0.17 0.04
 CIDRa1.A − 0.03 0.75 0.18 0.02
 CIDRa1.4 0.02 0.73 0.18 0.02
 CIDRa1.5 − 0.08 0.31 0.05 0.50
 CIDRa1.6 − 0.03 0.71 0.07 0.37
 CIDRa1.7 − 0.09 0.23 0.08 0.28
CIDRa1.DC8 0.08 0.28 0.15 0.06
 CIDRa1.1 0.18 0.02 0.25 0.001*
 CIDRa1.8 − 0.04 0.56 0.07 0.40
CIDRa3.1/2 0.15 0.05 0.10 0.23
UPSB 0.03 0.69 0.03 0.72
VAR2CSA − 0.11 0.16 − 0.02 0.78
Var3 0.13 0.12 0.02 0.83
CIDRd 0.09 0.21 − 0.02 0.81
CIDRg 0.04 0.59 − 0.04 0.59
DBLz 0.03 0.71 0.10 0.19
DBLe 0.03 0.66 − 0.03 0.75
DC5 0.03 0.74 − 0.05 0.51
Table 2.  Correlations of ADAM17 and Ang2 Plasma levels. *Statistically significant correlations when 
applying Bonferroni’s correction for multiple testing with 24 independent tests for ADAM17 and Ang2 each 
(P ≤ 0.002 considered statistically significant, DBLα 1all, CIDRα 1.all, CIDRα 1.A, and CIDRα 1.DC8 were not 
counted as they represent summations). CIDRα 1.all = Sum of all primers targeting transcripts encoding CIDRα 
1s predicted to bind EPCR. CIDRa1.A EPCR = Sum of all transcript abundances reported by primers targeting 
genes encoding Group A CIDRα 1s predicted to bind EPCR. CIDRα 1.DC8 = Sum of all reported transcripts 
encoding Group B/A CIDRα 1s predicted to bind EPCR. Spearman’s rank correlation coefficients (Rho) 
calculated for uncomplicated and severe acute malaria patients.
Model Estimate P
Hb (g/dL) − 0.03 0.001
Lactate 0.02 0.004
CIDRα1.4 0.003 0.004
Log10 (ADAM17) (pg/ml) 0.15 0.02
Location 2 0.2 0.0001
Table 3.  Statistically significant explanatory variables in a multiple linear regression analysis of 
transformed Ang2 levels in hospitalized malaria patients.
Model Estimate P
Age (years) − 0.05 0.002
Log10 (Ang2 pg/ml) 0.25 0.005
Table 4.  Statistically significant explanatory variables in a multiple linear regression analysis of 
transformed ADAM17 levels in hospitalized malaria patients.
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of EPCR-binding PfEMP1. Rather, expression of PfEMP1 with CIDRα 1.1 domains was weakly correlated with 
ADAM17 plasma levels, although this correlation was not statistically significant when correcting for multiple 
testing, and lost after adjusting for age by general multiple linear regression analysis. This suggests that PfEMP1 
expression and ADAM17 levels in the plasma are not directly affecting each other during malaria.
Previously, Abdi et al., showed that Ang2 plasma levels were associated with group A-like PfEMP1 expression 
and rosetting29, and that Ang2 levels were associated with development of the specific SM clinical manifestations 
RD and CM. A-type PfEMP1 expression was only associated with CM and not RD, and Abdi et al. concluded 
that Ang2 plasma levels and group A-like PfEMP1 expression were independently associated with impaired 
consciousness and CM29. Using a comprehensive set of var type specific primers we found that Ang2 levels are 
specifically correlated with expression of var genes encoding PfEMP1s predicted to bind EPCR. DBLα 1 domain 
expression measured with primers targeting group A PfEMP1s (DBLα 1all) correlated with Ang2, similarly to 
what Abdi et al. reported, while further division of the group A showed that only the subtype of group A (tar-
geted by primer DBLα 2/1.1/4/7) genes predicted to bind EPCR correlated with Ang2, and expression of group A 
PfEMP1 predicted not to bind EPCR did not correlate with Ang2. Furthermore, measurements of additional var 
genes encoding PfEMP1s not predicted to bind EPCR, including group B PfEMP1 (UPSB), PfEMP1 containing 
CIDRα 3.1/2 predicted to bind CD36 or chondroitin sulfate A (VAR2CSA), did not correlate with plasma levels 
of Ang2.
We did not find a correlation between the transcript levels of all analysed CIDRα 1 domains predicted to bind 
EPCR, so caution is warranted in interpreting the found correlations, but it could be due to less prevalence of 
CIDRα 1 expression of these subtypes in the infecting parasites. Our measurements of PfEMP1 expression are 
not able to fully account for the increase in Ang2 observed in SM, and cannot alone explain the increase in Ang2 
observed in SM, as underlined by our multiple linear regression analysis of Ang2 levels. So while Abdi et al. 
reports that endothelial activation and group A expression are independently associated with CM, we find that 
part of the Ang2 plasma level which is increased in SM, is associated with EPCR-binding PfEMP1 expression, 
even when including other factors associated with increased Ang2 in the analysis, such as lactate and Hb.
Recently, an analysis of full-length var transcripts in UM and SM groups revealed that they mainly differ in 
relation to an increased expression of EPCR-binding PfEMP1 in SM, but with no major differences in var tran-
scripts between SMA and CM groups33.
In summary, these data suggest that ADAM17 plasma levels increase in response to malaria infection similarly 
to that of other infectious diseases and that the association between Ang2 levels and var gene transcript levels, 
although weak, is specific for EPCR-binding PfEMP1s. Furthermore, PfEMP1s predicted to bind EPCR may be 
associated with the endothelial activation accompanying SM, reinforcing the notion that EPCR-binding PfEMP1s 
are linked to SM pathogenesis (Supplementary Fig. S3).
Methods
Sample collection. A total of 213 children admitted to Korogwe and Magu District Hospitals, in north-east-
ern and north-western Tanzania, respectively, were enrolled as part of an ongoing monitoring of malaria at the 
hospitals. 181 children were blood smear positive for P. falciparum. For 19 children admitted to the Korogwe 
District Hospital with malaria, blood samples were drawn at admission and at follow-up between 2 and 12 weeks 
after admission. None were malaria positive at follow-up by rapid diagnostic tests. 32 of the children admitted to 
Korogwe District Hospital with infectious diseases other than malaria were included as non-malaria hospitalized 
children and also a part of a previous study34 (Supplementary Table S1). The patient samples included in this 
study were selected from a database to reflect the main clinical manifestations associated with high mortality; (I) 
CM was diagnosed if the Blantyre coma score was < 335), (II) SMA if the haemoglobin (Hb) level was < 5 g/dl, 
(III) if there were clinical signs of RD (Kussmaul deep breathing and/or chest indrawing), or (IV) if hyperparasi-
taemia was observed (> 200,000 parasites/μ l). Children fulfilling any of the above criteria were categorized as SM. 
Children not fulfilling any of these criteria were categorized as UM. Plasma samples from six non-hospitalized 
children as part of a malariometric survey in the Korogwe district with asymptomatic malaria were included in 
the study.
Ethics statement. Written informed consent was obtained from the parents or guardian of all the study par-
ticipants. All patients received treatment according to the national guidelines. The studies and experiments were 
reviewed and approved by the National Institute for Medical Research, Tanzania (reference no. NIMR/HQ/R.8c/
Vol.II/436), and the methods in this study were perfomed in accordance with the approved guidelines.
Detection of plasma proteins. The plasma samples were diluted in phosphate buffered saline (PBS) + 
1% bovine serum albumin (BSA), between 1:2 and 1:6 for ADAM17 and 1:5 for Ang2, and ADAM17 and Ang2 
plasma levels were detected using DuoSet ELISA Development kit (R&D Systems) according to manufacturer’s 
instructions. A four parameter logistic curve was fitted to a serial dilution of a recombinant protein standard of 
known concentration for each ELISA plate, in order to convert optical densities to protein concentration.
The PfHRP2 plasma levels were determined using an ELISA assay as previously described36, with the following 
modifications: Maxisorp plates (NUNC, Roskilde, Denmark) were coated with 1.0 μ g/mL immunoglobulin M 
monoclonal anti-HRP2 antibody (MPFM-55a, Immunology Consultants Laboratories, Portland, USA) diluted 
in PBS and incubated overnight at 4 °C. Plates were blocked with 3% skimmed milk in PBS for 2 hours. Between 
each step the plates were washed in 0.05% Tween-20 and PBS. Plasma samples were diluted 1:64 in 1% skimmed 
milk and PBS, added to the plates and incubated for 2 hours. Secondary antibody conjugated with horserad-
ish peroxidase (MPFG-55P, Immunology Consultants Laboratories; 0.2 μ g/mL diluted in 1% skimmed milk and 
PBS) was added to each well and incubated for 1 hour at room temperature. Substrate, TMB ease (Kem-En-Tec 
Diagnostics), was added and the reaction was stopped with 0.2 M H2SO4. The plates were read using a plate reader 
www.nature.com/scientificreports/
8Scientific RepoRts | 6:35950 | DOI: 10.1038/srep35950
at an OD of 490. A serial dilution of a recombinant HRP2 protein (Cat no MBS5303860, MyBioSource, San Diego, 
USA) was made for each plate in order to convert optical densities to protein concentration as for ADAM17 and 
Ang2.
Var transcript abundances. Data of transcript abundances of var gene subtypes were generated using 
quantitative PCR by Mkumbaye et al., (submitted) as previously described7, although using redesigned primers 
targeting loci specific for different PfEMP1 domains. The qPCR primer sets were optimized for optimal cover-
age of var genes encoding specific subclasses of DBL and CIDR domains. Supplementary Table S2 provides an 
overview of the estimated var type coverage of the primers used in this study. qPCR was performed in 20-μ L 
reactions using QuantiTect SYBR Green PCR master mix (Qiagen) with the Rotorgene thermal cycler system 
(Corbett Research), and the transcript abundance was determined relative to the averaged transcript abundance 
of seryl-tRNA synthetase and fructose-bisphosphate aldolase, as previously described7. Summation of var transcript 
levels reported by primers targeting var transcripts encoding PfEMP1 with similar receptor binding specificity 
was done for: PfEMP1 with CIDRα 1 domains predicted to bind EPCR (CIDRa1.all): primer sets CIDRa1.1, 
CIDRa1.4, CIDRa1.5, CIDRa1.6, CIDRa1.7, and CIDRa1.8; Group A CIDRα 1 domains predicted to bind EPCR 
(CIDRa1.A): primer sets CIDRa1.4, CIDRa1.5, CIDRa1.6, and CIDRa1.7; and DC8 (CIDRα 1.DC8): primer sets 
CIDRa1.1 and CIDRa1.8.
Statistical analysis. Normally distributed variables, such as age, were compared by Welch’s Two Sample 
t-test. For comparing acute and convalescent ADAM17 plasma levels, Wilcoxon’s paired signed rank test was 
used to calculate statistical significance. For comparisons of multiple groups, the non-parametric Kruskal-Wallis 
test was used, while differences between groups were calculated by pairwise comparisons using Dunn’s test with 
Bonferroni’s correction. For univariate correlations, Spearman’s rank correlation was used to determine the cor-
relation coefficient Rho. Bonferroni’s correction was applied to the spearman’s rank correlations; ADAM17 and 
Ang2 were considered independent tests, so 24 components were included in the correction for each (DBLα 
1all, CIDRα 1.all, CIDRα 1.A, and CIDRα 1.DC8 were not counted as they represent summations of primers that 
are included by themselves) and thus correlations were considered statistically significant when the P-value was 
below 0.002. General linear regression analysis was performed, in which we included the univariate correlations 
with a P value below 0.05. Backwards elimination was performed with multiple iterations, each time removing 
the variable with the highest P-value above the significance level, until only statistically significant explanatory 
variables remained. Statistical analyses were performed using the statistical software R. A P-value below 0.05 was 
considered statistically significant.
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